Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
PaperCitations, authors & open-access status
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 383 citations, 2018 year and green oa status.
383
Citations
2018
Year
green
OA Status